| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2005 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 1 | 0.449 | 0.923 | 0.12 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 1988 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 1989 | 2020 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.200 | None | 0.941 | 17 | 0 | 2003 | 2019 | ||||||||
|
preferentially expressed antigen in melanoma | 0.531 | 0.577 | 2.4E-07 |
|
disease | 0.400 | None | 1.000 | 16 | 0 | 1998 | 2019 | ||||||||
|
major histocompatibility complex, class I, G | 0.461 | 0.769 | 1.4E-11 |
|
disease | 0.100 | None | 0.941 | 16 | 0 | 1999 | 2018 | ||||||||
|
Jun proto-oncogene, AP-1 transcription factor subunit | 0.442 | 0.885 | 6.0E-02 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 1998 | 2019 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2011 | 2019 | |||||||||
|
secreted protein acidic and cysteine rich | 0.445 | 0.846 | 0.89 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 1997 | 2014 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2008 | 2018 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 1994 | 2019 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1988 | 2012 | ||||||||
|
neurofibromin 1 | 0.440 | 0.885 | 0.90 |
|
disease | 0.600 | None | 1.000 | 15 | 0 | 1993 | 2018 | ||||||||
|
forkhead box P3 | 0.368 | 0.846 | 0.99 |
|
disease | 0.100 | None | 0.882 | 15 | 0 | 2007 | 2019 | ||||||||
|
phospholipase A and acyltransferase 4 | 0.500 | 0.808 | 1.2E-07 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2006 | 2019 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
disease | 0.700 | None | 1.000 | 15 | 0 | 1999 | 2018 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2000 | 2020 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 1994 | 2015 | ||||||||
|
interleukin 15 | 0.422 | 0.846 | 0.71 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 1995 | 2019 | ||||||||
|
KiSS-1 metastasis suppressor | 0.507 | 0.808 | 0.49 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 1997 | 2018 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
disease | 0.400 | None | 1.000 | 14 | 0 | 2002 | 2019 | ||||||||
|
matrix metallopeptidase 14 | 0.447 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2000 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 0.875 | 14 | 0 | 1989 | 2018 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2013 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.100 | None | 0.929 | 13 | 0 | 1994 | 2010 |